Your browser doesn't support javascript.
loading
Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors.
Manson, Guillaume; Lemchukwu, Amaeshi Chukwunonye; Mokrane, Fatima-Zohra; Lopci, Egesta; Aide, Nicolas; Vercellino, Laetitia; Houot, Roch; Dercle, Laurent.
Afiliação
  • Manson G; Department of Hematology, University Hospital of Rennes, INSERM U1236, 2 rue Henri le Guilloux, 35 000, Rennes, France. Guillaume.manson@chu-rennes.fr.
  • Lemchukwu AC; Department of Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Mokrane FZ; Department of Radiology, University Hospital of Toulouse, Toulouse, France.
  • Lopci E; Nuclear Medicine, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, MI, Italy.
  • Aide N; Nuclear Medicine Department, Caen University Hospital, Caen, France.
  • Vercellino L; Department of Nuclear Medicine, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), Paris, France.
  • Houot R; Department of Hematology, University Hospital of Rennes, INSERM U1236, 2 rue Henri le Guilloux, 35 000, Rennes, France.
  • Dercle L; Department of Radiology, Columbia University Medical Center, New York, NY, USA.
Eur Radiol ; 32(9): 6536-6544, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35344061
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Fluordesoxiglucose F18 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Fluordesoxiglucose F18 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article